

Vivitra 440 mg Injection is a prescription medicine used in the treatment of HER2-positive breast and gastric cancers. It contains Trastuzumab, a targeted therapy that helps slow or stop the growth of cancer cells by specifically blocking HER2 receptors. This injection is given under medical supervision through intravenous infusion. Vivitra 440 mg Injection is suitable for patients whose cancer cells overexpress the HER2 protein. Regular use as directed by an oncologist helps improve treatment outcomes and supports a more effective cancer management plan alongside chemotherapy or as monotherapy.
| SKU | CMS3090 |
| USA Brand Name | Vivitra |
| Strength | 440mg |
| Generic Name | Trastuzumab |
| Manufacturer | Zydus Cadila |
| Variant | Price | Units | Quantity | Add to Cart |
|---|---|---|---|---|
| 2 Injection | $1,674.40 | $837.20 | ||
| 4 Injection | $3,261.44 | $815.36 | ||
| 6 Injection | $4,804.80 | $800.80 |
| size | 2 Injection, 4 Injection, 6 Injection |
|---|
Reviews
There are no reviews yet.